FCBT
NEO icon

First Citizens Bank & Trust’s NeoGenomics NEO Stock Holding History

First Citizens Bank & Trust’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,035
Closed -$291K – 439
2021
Q3 		$291K Buy
+6,035
New +$279K 0.01% 296

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Citizens Bank & Trust's NEO Position: Q4 2021 in Review

First Citizens Bank & Trust sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 6,035 shares — an estimated $291K sold.

First Citizens Bank & Trust first reported a position in NEO in Q3 2021 and held it in 1 quarter. The position peaked at $291K in Q3 2021. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • First Citizens Bank & Trust reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • First Citizens Bank & Trust sold 6,035 NeoGenomics shares in Q4 2021, an estimated $291K.
  • First Citizens Bank & Trust first reported a position in NeoGenomics in Q3 2021 and held it in 1 quarter.
  • First Citizens Bank & Trust's NeoGenomics position peaked at $291K in Q3 2021.
  • 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on First Citizens Bank & Trust's 13F filing for Q4 2021, filed 11 Mar 2022.